The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 2754692 |
20 |
Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted benzolactams. |
Merck Sharp & Dohme Research Laboratories |
| 2477546 |
16 |
Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin. |
Centre De Pharmacologie-Endocrinologie (Montpellier, France) |
| 3336026 |
18 |
Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines. |
Merck Sharp & Dohme Research Laboratories |
| 2441054 |
18 |
Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds. |
TBA |
| 3761313 |
22 |
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility. |
TBA |
| 26654202 |
99 |
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex. |
Mayo Clinic |
| 25434976 |
2 |
Spirotetronate polyketides as leads in drug discovery. |
University of California San Diego |
| 16250639 |
32 |
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists. |
James Black Foundation |
| 15456276 |
45 |
5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptors. |
Instituto De Qu£Mica M£Dica (Csic) |
| 11708921 |
28 |
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structure-activity relationship studies on the central 1,3-dioxoperhydropyrido[1,2-c]pyrimidine scaffold. |
Instituto De Qu£Mica M£Dica (Csic) |
| 11405658 |
12 |
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1)receptor antagonists: structure-activity relationship studies on the substituent at N2-position. |
Instituto De Qu£Mica M£Dica (Csic) |
| 11020292 |
34 |
beta-Turned dipeptoids as potent and selective CCK(1) receptor antagonists. |
Instituto De Qu£Mica M£Dica (Csic) |
| 10882360 |
17 |
CCK peptides with combined features of hexa- and tetrapeptide CCK-A agonists. |
Astrazeneca R&D Boston |
| 10579828 |
28 |
5-(Tryptophyl)amino-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based potent and selective CCK(1) receptor antagonists: structural modifications at the tryptophan domain. |
Insituto De Qu�Mica M�Dica (Csic) |
| 9057851 |
30 |
Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor. |
University of Paris |
| 9435899 |
18 |
Synthesis and biological evaluation of potent, selective, hexapeptide CCK-A agonist anorectic agents. |
Rochester |
| 9397175 |
48 |
Synthesis and biological properties of new constrained CCK-B antagonists: discrimination of two affinity states of the CCK-B receptor on transfected CHO cells. |
University of Paris |
| 7966139 |
6 |
Peptide-linked 1,3-dialkyl-3-acyltriazenes: gastrin receptor directed antineoplastic alkylating agents. |
National Cancer Institute-Frederick |
| 8421283 |
43 |
CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives. |
University of Paris |
| 1732532 |
139 |
Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives. |
Rotta Research Laboratorium |
| 2885419 |
179 |
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. |
TBA |
| 14698161 |
10 |
Synthesis and biological characterisation of [3H]BBL454, a new CCK2 selective radiolabelled agonist displaying original pharmacological properties. |
University of Paris |
| | 32 |
Pseudopeptide CCK-4 analogues incorporating the [CH(CN)NH] peptide bond surrogate |
TBA |
| | 31 |
Identification and biological activity of novel peptidomimetic gastrin/CCK-B receptor agonists |
TBA |
| 21456601 |
26 |
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor. |
University Medical Centre Ljubljana |
| | 30 |
CCK-4 restricted analogues containing a 3-oxoindolizidine skeleton |
TBA |
| | 29 |
Synthesis and biological activity of 5-heteroaryl benzodiazepines: analogues of YM022 |
TBA |
| | 25 |
Synthesis and biological activity of 1-alkylcarbonylmethyl analogues of YM022 |
TBA |
| | 18 |
On the significance of the C-terminal primary amide in cholecystokinin |
TBA |
| | 16 |
Structure-based design and pharmacological properties of potent selective and systemically active CCK-B peptidomimetics |
TBA |
| 16302807 |
34 |
Conformationally constrained CCK4 analogues incorporating IBTM and BTD beta-turn mimetics. |
Instituto De QuíMica MéDica (Csic) |
| 16033264 |
48 |
Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor. |
Instituto De QuíMica MéDica (Csic) |
| 11755332 |
10 |
Effects of the incorporation of IBTM beta-turn mimetics into the dipeptoid CCK(1) receptor agonist PD 170292. |
Instituto De QuíMica MéDica (Csic) |
| 11020275 |
75 |
Replacement of glycine with dicarbonyl and related moieties in analogues of the C-terminal pentapeptide of cholecystokinin: CCK(2) agonists displaying a novel binding mode. |
University of Paris |
| 9871777 |
28 |
Novel constrained CCK-B dipeptoid antagonists derived from pipecolic acid. |
University of Paris |
| 9341915 |
24 |
Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists. |
Instituto De QuíMica MéDica (Csic) |
| 9022799 |
38 |
(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist. |
Ferring Research Institute |
| 8411007 |
392 |
Chemistry, binding affinities, and behavioral properties of a new class of"antineophobic" mitochondrial DBI receptor complex (mDRC) ligands. |
Mayo Foundation |
| 8411002 |
67 |
Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties. |
University of Paris |
| 8246239 |
84 |
Development of high-affinity 5-HT3 receptor antagonists. Structure-affinity relationships of novel 1,7-annelated indole derivatives. |
Solvay Duphar |
| 7692048 |
48 |
Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid. |
Ep Cnrs 51 |
Search and Browse
